Stonepine Capital Management, LLC Portfolio Holdings
Stonepine Capital Management, LLC
- $126 Billion
- Q1 2024
Stonepine Capital Management, LLC has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $126 Billion distributed in 20 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Evolus, Inc. with a value of $37.4B, Adma Biologics, Inc. with a value of $22.6B, Alimera Sciences Inc with a value of $15.8B, Galapagos Nv with a value of $12.7B, and Revance Therapeutics, Inc. with a value of $9.72B.
Examining the 13F form we can see an decrease of $105B in the current position value, from $231B to 126B.
Stonepine Capital Management, LLC is based out at Bend, OR
Below you can find more details about Stonepine Capital Management, LLC portfolio as well as his latest detailed transactions.